CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Effective Income Tax Rate Reconciliation, Tax Contingency, Foreign, Amount
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Effective Income Tax Rate Reconciliation, Tax Contingency, Foreign, Amount of -$27.00 million for the 6-month period ending 2011-06-25, per its 10-Q filed 2011-08-03.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationTaxContingenciesForeign · last filed 2011-08-03
- 2011-06-25: Effective Income Tax Rate Reconciliation, Tax Contingency, Foreign, Amount 6 month -$27.00M.
| Period end | Effective Income Tax Rate Reconciliation, Tax Contingency, Foreign, Amount 6 month |
|---|---|
| 2011-06-25 | -$27.00M 10-Q · filed 2011-08-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |